Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug promotion and labeling in developing countries: an update.

P R Lee1, P Lurie, M M Silverman

  • 1Institute for Health Policy Studies, University of California, San Francisco.

Journal of Clinical Epidemiology
|January 1, 1991
PubMed
Summary

Multinational drug companies improved promotion in developing nations, but national companies did not. Fraudulent drug products remain a serious issue, with some containing no active ingredients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of epidemiology in informing United States childhood immunization policy and practice.

Annals of epidemiology·2020
Same author

TRPM8 Mediates Hyperosmotic Stimuli-Induced Nociception in Dental Afferents.

Journal of dental research·2019
Same author

TRPM7 Mediates Mechanosensitivity in Adult Rat Odontoblasts.

Journal of dental research·2018
Same author

Piezo2 Expression in Mechanosensitive Dental Primary Afferent Neurons.

Journal of dental research·2017
Same author

Risk factors for hospital and long-term mortality of critically ill elderly patients admitted to an intensive care unit.

BioMed research international·2015
Same author

Spin-induced band modifications of graphene through intercalation of magnetic iron atoms.

Nanoscale·2014

Area of Science:

  • Pharmaceutical Marketing
  • Global Health Policy
  • Drug Regulation

Background:

  • Previous studies (since 1972) highlighted exaggerated drug indications and minimized hazards by multinational and national companies in developing countries.
  • Recent policy changes in multinational corporations' drug promotion and labeling practices have been observed.

Purpose of the Study:

  • To assess changes in drug promotion and labeling policies of multinational corporations in developing countries since 1972.
  • To identify persistent issues in drug marketing, including fraudulent products, in Third World countries.

Main Methods:

  • Comparative analysis of drug promotion and labeling practices over time.
  • Identification and reporting of fraudulent drug products in various Third World markets.

Related Experiment Videos

Main Results:

  • Multinational corporations showed considerable improvement in promotional practices since 1987.
  • National companies exhibited little to no improvement, continuing exaggerated claims and downplaying drug hazards.
  • A significant problem of fraudulent drug products, mimicking original brands but lacking active ingredients, was identified in several countries.

Conclusions:

  • While multinational corporations have improved, national drug companies' practices remain problematic, impacting physician information.
  • The widespread marketing of fraudulent drug products poses a serious threat to public health in developing nations.
  • Urgent regulatory attention is needed to address substandard and counterfeit pharmaceuticals in markets like Indonesia, Brazil, Thailand, Bangladesh, and Malaysia.